Education
About Us
Working with TipRanks
Follow Us
Bionano Genomics (BNGO)
:BNGO
BNGO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.68 - $37.09
Previous CloseN/A
Volume11.48M
Average Volume (3M)92.47K
Market Cap
$10.09M
Enterprise Value$39.10M
Total Cash (Recent Filing)$18.23M
Total Debt (Recent Filing)$18.41M
Price to Earnings (P/E)―
Beta2.56
Next Earnings
Aug 14, 2025EPS Estimate
-2.63Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,364,000
10 Day Avg. Volume83,438
30 Day Avg. Volume92,474
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap3.87
Enterprise Value/Revenue1.37
Enterprise Value/Gross Profit40.73
Enterprise Value/Ebitda-0.51
Forecast
1Y Price Target
$8.00Price Target Upside162.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Business RestructuringBionano has made significant progress in restructuring its business, including discontinuing non-core business lines and lowering headcount.
Market PositionWith a second CPT code now in place, integration into diagnostic workflows at leading institutions, and a continuing flow of publications, the company is well-positioned to drive further adoption and grow revenues.
Technological AdvantageOGM has been shown to outperform the current gold standard cytogenetic methods for the detection of structural variation (SV).
Bears Say
Customer ActivityBionano witnessed a 15% year-over-year decline in flowcells to its customers.
Financial VisibilityGiven the company's outlook for flattish growth and lack of visibility on how BNGO plans to finance the business, the Neutral rating is reiterated.
Revenue GuidanceBionano lowered its 2025 revenue guidance to factor in global trade and uncertainty.
BioNano Genomics News
BNGO FAQ
What was Bionano Genomics’s price range in the past 12 months?
Bionano Genomics lowest stock price was $2.68 and its highest was $37.09 in the past 12 months.
What is Bionano Genomics’s market cap?
Bionano Genomics’s market cap is $10.09M.
When is Bionano Genomics’s upcoming earnings report date?
Bionano Genomics’s upcoming earnings report date is Aug 14, 2025 which is in 6 days.
How were Bionano Genomics’s earnings last quarter?
Currently, no data Available
Is Bionano Genomics overvalued?
According to Wall Street analysts Bionano Genomics’s price is currently Undervalued.
Does Bionano Genomics pay dividends?
Bionano Genomics does not currently pay dividends.
What is Bionano Genomics’s EPS estimate?
Bionano Genomics’s EPS estimate is -2.63.
How many shares outstanding does Bionano Genomics have?
Bionano Genomics has 3,364,000 shares outstanding.
What happened to Bionano Genomics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bionano Genomics?
Currently, no hedge funds are holding shares in BNGO
BioNano Genomics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (162.30% Upside)
$8.00 (162.30% Upside)
Blogger Sentiment
Bullish
BNGO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 8.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 8.7%
Last 30 Days ▼ 8.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-88.68%
12-Months-Change
Fundamentals
Return on Equity
-127.82%
Trailing 12-Months
Asset Growth
-50.37%
Trailing 12-Months
Company Description
Bionano Genomics
BioNano Genomics (BNGO) is a life sciences instrumentation company that develops and markets solutions for genome analysis. The company specializes in providing advanced genomic diagnostic tools and services to researchers and clinicians, with a focus on optical genome mapping using its proprietary Saphyr system. This technology enables the detection of structural variations in DNA, which are crucial for understanding various diseases, including cancer and genetic disorders.
BNGO Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant improvements in gross margin and reductions in operating expenses, driven by a successful strategic shift and a focus on routine users. However, these positive developments are counterbalanced by a notable decrease in revenue and flowcell sales, and challenges related to global trade uncertainties.View all BNGO earnings summariesBNGO Stock 12 Month Forecast
Average Price Target
$8.00
▲(162.30% Upside)
Technical Analysis
Enzo Biochem
―
Burning Rock Biotech
―
Intelligent Bio Solutions
―
Mainz Biomed B.V.
―
bioAffinity Technologies, Inc.
―
Ownership Overview
5.72% Insiders
2.25% Mutual Funds
1.34% Other Institutional Investors
90.43% Public Companies and Individual Investors